Startup using genetics to enhance athletic performance
This isn't at the level of genetic doping - but it's an early step in plumbing one's genes to optimize athletic performance.
This isn't at the level of genetic doping - but it's an early step in plumbing one's genes to optimize athletic performance.
The Province of Nova Scotia is lending $5 million to clinical-stage biotech Immunovaccine, which is developing an adjuvant platform that could make cancer vaccines more effective more quickly. The technology, aptly named DepoVax, creates a “depot” at the site of injection, attracting the immune system’s antigen-presenting cells to take up the vaccine. It’s used with […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.